Mark E. Salvati
34Patents
8h-index
81Co-inventors
74Inventor score
Filing activity: Jun 28, 1999 → Dec 18, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6288082A | Substituted 3-cyanoquinolines | Chemistry; Metallurgy | 97 | Expired |
| US6960474B2 | Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator | Human Necessities | 61 | Expired |
| US6670386B2 | Bicyclic modulators of androgen receptor function | Chemistry; Metallurgy | 33 | Expired |
| US7001911B2 | Fused cyclic modulators of nuclear hormone receptor function | Chemistry; Metallurgy | 17 | Expired |
| US6900208B2 | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6022307A | Substituted dibenzothiophenes having antiangiogenic activity | Chemistry; Metallurgy | 12 | Expired |
| US6953679B2 | Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof | Chemistry; Metallurgy | 12 | Expired |
| US7030112B2 | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders | Chemistry; Metallurgy | 11 | Expired |
| US6992102B2 | Bicyclic modulators of androgen receptor function | Chemistry; Metallurgy | 7 | Expired |
| US7888376B2 | Heterocyclic CETP inhibitors | Chemistry; Metallurgy | 7 | Active |
| US7141578B2 | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | Chemistry; Metallurgy | 6 | Expired |
| US7790770B2 | Heterocyclic CETP inhibitors | Chemistry; Metallurgy | 5 | Active |
| US7087636B2 | Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function | Chemistry; Metallurgy | 4 | Expired |
| US7655688B2 | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | Human Necessities | 3 | Active |
| US6795776B1 | Crystallographic structure of the androgen receptor ligand binding domain | Physics | 3 | Expired |
| US6414156B2 | Process for preparing azacycloalkanoylaminothiazoles | Chemistry; Metallurgy | 3 | Expired |
| US6639074B2 | Process for preparing azacycloalkanoylaminothiazoles | Chemistry; Metallurgy | 1 | Expired |
| US8304403B2 | Heterocyclic CETP inhibitors | Chemistry; Metallurgy | 1 | Active |
| US7776859B2 | Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function | Chemistry; Metallurgy | 1 | Active |
| US7432267B2 | Fused cyclic modulators of nuclear hormone receptor function | Chemistry; Metallurgy | 1 | Active |
| US7550458B2 | Tricycloundecane compounds useful as modulators of nuclear hormone receptor function | Chemistry; Metallurgy | 1 | Active |
| US7291637B2 | Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function | Chemistry; Metallurgy | 0 | Expired |
| US6610724B2 | 3-Aminopyrazole inhibitors of cyclin dependent kinases | Human Necessities | 0 | Expired |
| US8404896B2 | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases | Chemistry; Metallurgy | 0 | Active |
| US8642576B2 | Heterocyclic CETP inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.